Imiquimod (IMQ) is a heterocyclic imidazoquinolinone amide that is an immune response modifier, with potent antiviral and anti-tumour activity. It has been employed in the treatment of non-cancerous dermatoses as well. Some of them include verruca vulgaris, molluscum contagiosum, granuloma annulare, morphoea, stucco keratosis and porokeratosis.